RHHBF - Roche: The Recent Sell-Off Created A 30% Upside Potential

2024-02-11 07:04:47 ET

Summary

• Roche is a well-recognized pharmaceutical company with a strong international presence and a market capitalization of CHF 187 billion.
• Despite recent challenges, Roche's 2024 guidance shows potential for mid-single-digit growth in revenues and EPS, making it an interesting opportunity for long-term investors.
• We believe that the last few months decline could increase the interest of value investors as the stock is trading at historically low multiple valuation.
• Both a DCF model and a multiple analysis indicate a plus 30% upside potential for the stock.

Description

The Swiss company Roche (RHHBY) (RHHBF) (RHHVF) is one of the most well-recognized brands in the pharmaceutical sector. It has a CHF 187 billion market capitalization and annual revenues of CHF 58.7 billion (2023 data). With a 2.7% weight, it is the tenth largest company by weight within the MSCI world healthcare index ....

For further details see: